Overview

Cancer is a group of diseases in which abnormal cells grow uncontrollably and may spread to other parts of the body. When cancer is detected at an early stage, treatment is often more effective and may involve less extensive treatment in some cases. This underscores the importance of early cancer detection in cancer control.

One way to detect certain cancers early is through screening tests. Screening is designed for people who do not have symptoms and aims to identify cancer or pre-cancerous changes before symptoms develop. It is different from diagnostic testing, which is performed when a person has symptoms or an abnormal clinical finding.

Not every cancer has a recommended screening test and having more tests does not necessarily mean better cancer prevention. Screening tests can sometimes yield false-positive or false-negative results and may prompt additional investigations. Therefore, screening should be based on evidence, age, personal risk factors and appropriate medical advice.

For people in India, awareness of screening is particularly important for cancers such as breast, cervical and oral cancer. These cancers are among the common malignancies in the country and can be detected at earlier stages through appropriate screening and early diagnosis strategies.

This guide explains the importance of cancer screening tests, the common types available, who may benefit from them and why regular medical assessment remains important even when a person is not eligible for routine screening.

What Are Cancer Screening Tests?

Cancer screening tests are examinations or investigations used to identify possible cancer or pre-cancerous changes in people who may not have any symptoms.

The purpose is to identify the disease early enough for further evaluation and treatment.

Examples of cancer screening tests include:

• Mammography for breast cancer screening

• HPV testing and cervical screening methods for cervical cancer

• Faecal tests and colonoscopy-based strategies for colorectal cancer

• Oral visual examination for oral cancer in appropriate high-risk populations

• Low-dose CT in selected people at high risk of lung cancer

The exact screening approach depends on the type of cancer, the person's age, risk factors and the recommendations of the healthcare provider.

A screening result is not the same as a cancer diagnosis. An abnormal screening result usually means that additional assessment is needed.

Why Is Cancer Screening Important?

Supporting Early Cancer Detection

Some cancers can develop without noticeable symptoms during their early stages. Screening can help identify abnormalities before a person becomes aware of them.

Early detection can enable timely diagnosis and treatment. WHO notes that early diagnosis and appropriate treatment can improve outcomes for many cancers.

Identifying Pre-Cancerous Changes

Some screening programmes can identify changes that may develop into cancer if left untreated.

Cervical cancer screening is an important example. Screening can identify cervical abnormalities and HPV infection that may require monitoring or treatment before invasive cancer develops.

Helping Reduce Cancer-Related Complications

When cancer is diagnosed before it has advanced significantly, treatment may be more manageable in some cases. The specific benefits depend on the type of cancer and the effectiveness of the screening programme.

Encouraging Preventive Healthcare

Regular discussions about screening can also encourage people to understand their personal cancer risk and address modifiable risk factors such as tobacco use, physical inactivity and unhealthy dietary patterns.

Screening and Early Diagnosis Are Not the Same

It is important to understand the difference between screening and early diagnosis.

Screening

Screening is intended for people without symptoms. It aims to identify people who may have cancer or pre-cancerous changes and who need further evaluation.

Early Diagnosis

Early diagnosis begins when a person develops symptoms or an abnormal finding. The goal is to investigate the symptoms promptly, establish a diagnosis and start appropriate treatment without unnecessary delay.

For example, a woman who has no breast symptoms may undergo screening according to her age and risk profile. A woman who discovers a new breast lump requires diagnostic assessment rather than simply waiting for her next screening appointment.

This distinction is important because cancer screening tests do not replace medical evaluation of symptoms.

Common Types of Cancer Screening Tests

1. Breast Cancer Screening

Breast cancer is one of the major cancers affecting women worldwide and is also a significant cancer burden in India.

Mammography

Mammography uses low-dose X-rays to create images of breast tissue. It can help identify abnormalities that may not yet be detectable through symptoms.

Depending on age, risk profile and local recommendations, mammography may be offered as part of breast cancer screening.

Clinical Breast Assessment

A healthcare professional may examine the breasts when symptoms or concerns arise. Clinical examination may also form part of certain screening or early detection approaches.

When Should Women Consider Breast Screening?

The appropriate age and frequency depend on individual risk and the screening recommendations followed in the region.

Women with a strong family history of breast cancer, known genetic risk or other significant risk factors may require an individualised screening plan and may be advised to start assessment earlier.

It is important to discuss personal risk with an oncologist, a breast specialist or an appropriate healthcare professional rather than relying on a general age-based recommendation.

2. Cervical Cancer Screening

Cervical cancer is largely preventable through vaccination against human papillomavirus (HPV), appropriate screening and timely treatment of pre-cancerous changes.

HPV Testing

High-risk types of HPV are responsible for most cervical cancers. HPV testing can identify high-risk HPV infection that may be associated with cervical abnormalities.

WHO identifies HPV DNA testing as a preferred cervical screening method where appropriate screening programmes are available.

Pap Smear

A Pap smear, also called cervical cytology, examines cells collected from the cervix for abnormal changes.

Depending on local recommendations and available screening programmes, Pap cytology may be used alone or as part of a broader cervical cancer screening strategy.

Visual Inspection Methods

Visual inspection methods may be used in some healthcare settings where appropriate, particularly where access to HPV testing or cytology is limited.

The most suitable screening method and interval should be determined according to local guidelines and individual circumstances.

3. Colorectal Cancer Screening

Colorectal cancer affects the colon and rectum. It can sometimes develop from pre-cancerous polyps that can be identified and removed during appropriate screening.

Faecal Immunochemical Test

A faecal immunochemical test, commonly called FIT, looks for tiny amounts of blood in stool that may not be visible to the naked eye.

An abnormal result does not necessarily mean that a person has cancer. Further investigation, often including colonoscopy, may be required.

Colonoscopy

Colonoscopy uses a flexible camera to examine the inside of the large bowel. It can identify polyps and other abnormalities and allows tissue sampling or removal of some polyps during the procedure.

Colorectal screening recommendations vary according to age and risk. Family history and previous polyps or colorectal cancer may result in an earlier or more intensive assessment.

WHO identifies regular screening as an effective approach for early detection and prevention of colorectal cancer in settings with organised screening programmes.

4. Oral Cancer Screening

Oral cancer is particularly relevant to cancer prevention and early detection in India.

A visual examination of the mouth can help identify suspicious changes such as persistent ulcers, unusual patches or other abnormalities.

People who use tobacco products, smoke or consume alcohol heavily may have an increased risk of oral cancer. Combining tobacco and alcohol use can further increase risk.

An oral examination does not confirm the presence of cancer. If a suspicious lesion is identified, further assessment may include specialist examination and biopsy.

IARC has identified cancers of the lip and oral cavity, along with breast and cervical cancer, as important targets for screening and early detection strategies in India.

5. Lung Cancer Screening

Lung cancer screening is not recommended for everyone.

For people at sufficiently high risk, particularly those with a significant history of tobacco smoking, low-dose CT may be considered within appropriate screening programmes.

The eligibility criteria can include factors such as age, smoking history and other risk factors. Screening recommendations vary between countries and healthcare systems.

A standard chest X-ray is not considered an equivalent replacement for an evidence-based lung cancer screening programme.

Anyone with symptoms such as a persistent cough, coughing up blood, unexplained weight loss, or ongoing breathlessness should seek medical assessment rather than wait for screening.

6. Prostate Cancer Assessment

Prostate cancer screening requires careful consideration because available tests can have limitations.

The prostate-specific antigen (PSA) blood test may be used as part of an assessment in appropriate men, particularly when symptoms or risk factors are present. However, PSA testing is not automatically appropriate as a routine screening test for every man.

An elevated PSA does not necessarily mean cancer is present. It can be increased by other prostate conditions.

Men with a strong family history, certain inherited genetic risks or other risk factors may need an individualised discussion with a healthcare professional about prostate cancer assessment.

Who Should Have Cancer Screening Tests?

There is no single screening schedule that applies to everyone.

Eligibility for screening can depend on:

• Age

• Sex

• Family history

• Genetic risk

• Previous medical conditions

• Tobacco or alcohol exposure

• Previous cancer or pre-cancerous changes

• Occupational or environmental exposures

• Lifestyle factors

• Local screening recommendations

People at average risk generally follow age-based recommendations where organised screening programmes are available.

People at higher risk may require a different screening strategy.

Who May Need Earlier or More Frequent Screening?

Certain people may benefit from an individualised cancer screening plan.

Strong Family History

A close relative with certain cancers may increase personal risk, particularly when multiple relatives are affected or cancer occurs at a younger age.

Inherited Genetic Conditions

Some inherited genetic changes can increase the risk of specific cancers. Individuals with a known inherited cancer syndrome may require specialised surveillance.

Previous Cancer

People who have previously been treated for cancer may require specific follow-up and surveillance based on their cancer type and treatment history.

Tobacco Use

Smoking and other forms of tobacco exposure increase the risk of several cancers, including lung and oral cancers.

Previous Pre-Cancerous Changes

People with previously identified pre-cancerous changes may need closer follow-up than the general population.

What Happens If a Screening Test Is Abnormal?

An abnormal screening result does not automatically mean that cancer is present.

Depending on the screening test, the next step may include:

• Repeat testing

• Specialist consultation

• Diagnostic imaging

• Endoscopy

• Colposcopy

• Biopsy

• Additional laboratory investigations

The purpose of these diagnostic tests is to determine whether cancer or a pre-cancerous condition is actually present.

Following up on an abnormal screening result is extremely important. Delaying recommended investigations can delay diagnosis and treatment.

Can Cancer Screening Tests Have Limitations?

Yes. No screening test is perfect.

Possible limitations include:

False-Positive Results

A test may suggest an abnormality even though cancer is not present. This can lead to additional investigations and anxiety.

False-Negative Results

A screening test may fail to detect a cancer that is present. This is why new or persistent symptoms should always be medically evaluated, even after a normal screening result.

Overdiagnosis

Some screening programmes may identify cancers that would not have caused significant problems during a person's lifetime. This can potentially lead to unnecessary treatment.

WHO highlights the importance of balancing the benefits of screening against potential harms, such as false-positive and false-negative results and overdiagnosis.

Cancer Screening Is Not Cancer Prevention

Cancer screening helps with early cancer detection, but it does not prevent every cancer.

Cancer prevention involves reducing exposure to known risk factors and adopting healthier habits.

Important preventive measures include:

• Avoiding tobacco

• Limiting alcohol consumption

• Maintaining a healthy weight

• Staying physically active

• Eating a balanced diet

• Protecting the skin from excessive ultraviolet exposure

• Following the recommended HPV and hepatitis B vaccination programmes

• Attending appropriate screening appointments

WHO estimates that a substantial proportion of cancers can currently be prevented through avoiding risk factors and implementing evidence-based prevention strategies.

What Symptoms Should Not Be Ignored?

Cancer screening is intended for people without symptoms. If symptoms develop, diagnostic evaluation should not be delayed simply because a person recently had a normal screening test.

Symptoms that may require medical assessment include:

• An unexplained lump or swelling

• Unexplained weight loss

• Persistent cough or change in voice

• Blood in the stool or urine

• Unexplained bleeding

• Persistent changes in bowel habits

• A sore or ulcer that does not heal

• Persistent difficulty swallowing

• Changes in a mole or skin lesion

• Persistent or unexplained pain

These symptoms can have many causes and do not necessarily indicate cancer. However, persistent or unexplained changes should be assessed by a healthcare professional.

How Can an Oncologist Help With Cancer Screening?

An oncologist specialises in the prevention, diagnosis and treatment of cancer and can help patients understand their individual cancer risk.

An oncology consultation may be appropriate when someone:

• Has a strong family history of cancer

• Has a known genetic risk

• Has an abnormal screening result

• Has previously had cancer

• Has concerning symptoms

• Needs guidance about an appropriate screening strategy

For people at increased risk, the oncologist may work with other specialists to develop an appropriate surveillance and diagnostic plan.

Frequently Asked Questions About Cancer Screening Tests

1. What are cancer screening tests?

Cancer screening tests are investigations used to detect certain cancers or precancerous changes in people without symptoms.

2. What is the purpose of cancer screening?

The primary purpose is to identify certain cancers or pre-cancerous changes early, when timely treatment may improve outcomes or prevent cancer from developing.

3. Does everyone need cancer screening?

Not everyone requires every type of screening. Screening depends on factors such as age, sex, personal risk, family history and applicable healthcare recommendations.

4. Which cancers can be screened for?

Established screening programmes exist for certain cancers, including breast, cervical and colorectal cancer. Screening may also be considered for selected high-risk individuals for other cancers.

5. Is a mammogram a cancer screening test?

Yes. Mammography is an important breast cancer screening method for appropriate women based on age and risk.

6. What is the best test for cervical cancer screening?

HPV testing is an important evidence-based screening method. Depending on the setting, cervical cytology and other approved methods may also be used. The appropriate method depends on local recommendations and individual circumstances.

7. Can a normal screening test rule out cancer completely?

No. Screening tests have limitations. New or persistent symptoms should be medically evaluated even after a normal screening result.

8. When should I start cancer screening?

The appropriate age varies according to the type of cancer, personal risk and applicable national or regional recommendations. People with increased risk may need earlier assessment.

9. Is cancer screening painful?

Some screening tests are minimally invasive, while others may cause temporary discomfort. The experience depends on the type of test.

10. Should I see an oncologist for cancer screening?

People at increased risk, those with abnormal screening results or those with concerning symptoms may benefit from an oncology consultation. For routine screening, a primary care doctor, gynaecologist or other relevant specialist may also guide the appropriate test.